Inflammation and Oxidation: Do They Improve After Kidney Transplantation? Relationship with Mortality After Transplantation

Overview

Journal Int Urol Nephrol

Publisher Springer

Specialty Nephrology

Date 2016 Dec 26

PMID 28013471

Citations 7

Authors

Laura Canas

Eva Iglesias

Maria Cruz Pastor

Jaume Barallat

Javier Juega

Ioana Bancu

Ricardo Lauzurica

Affiliations

Soon will be listed here.

Abstract

Objective: To evaluate the biomarkers which are associated with improvements in inflammation and lipid peroxidation in patients who have undergone KT. To evaluate the relationship between inflammation, lipid peroxidation and mortality in KT.

Patients: 196 KT (between 2003 and 2008). 67.9% men; median age: 51.9 years. Inflammation markers analyzed previous KT and 3 months after KT: c-reactive protein(CRP), interleukin 6(IL-6), tumor necrosis factor alpha(TNFα), soluble tumor necrosis factor receptor alpha(sTNFRα), soluble interleukin-2 receptor (sIL-2R). Lipid peroxidation markers analyzed: oxidized low-density lipoprotein (oxLDL) and anti-oxLDL antibodies. Calculation of glomerular filtration rate after KT: MDRD equation.

Results: Following KT, there is a significant decrease in CRP (p = 0.006), IL-6 (p = 0.0037), TNFα (p < 0.0001), sTNFRα (p < 0.0001) and sIL-2R (p < 0.0001), while levels of oxLDL increase after KT (p < 0.0001) and there is not a significantly difference in anti-oxLDL. 12.8% of the patients had died in 2012. These patients had higher levels of IL-6 (p = 0.011) and sTNFRα (p < 0.006) after KT and a lower MDRD (p < 0.0001), hemoglobin (p = 0.012) and albumin (p = 0.007). We observed no statistically differences in the levels of markers previous KT. Of the patients who died, the 43.5% of them had anti-oxLDL antibody levels greater than 75th percentile (P: 3781 UI/ml, p = 0.028). In the multivariate analysis, age (OR:1.12; p = 0.0129), MDRD (OR:0.92; p = 0.013) and P of anti-oxLDL(OR: 5.19; p = 0.026) were independent risk factors for mortality. Independent risk factors for survival were: P of IL-6 (HR: 2.45; p = 0.027), oxLDL (HR:19.85; p = 0.002) and anti-oxLDL (HR: 9.55; p = 0.003).

Conclusions: KT improved inflammation but not lipid oxidative state. KT patients who died had a higher inflammatory state (with higher levels of IL-6 and sTNFRα), a worse lipid oxidative state and a worse renal function 3 months after KT. Age, anti-oxLDL and renal function at 3 months after KT were independent risk factors for mortality.

Citing Articles

Levels of Cell-Free DNA in Kidney Failure Patients before and after Renal Transplantation.

Leotta C, Hernandez L, Tothova L, Arefin S, Ciceri P, Cozzolino M Cells. 2023; 12(24).

PMID: 38132094 PMC: 10741614. DOI: 10.3390/cells12242774.

Impact of kidney transplantation on the risk of retinal vein occlusion in end-stage renal disease.

Lee J, Choe H, Park S, Han K, Kim D, Joo K Sci Rep. 2021; 11(1):11583.

PMID: 34078921 PMC: 8172893. DOI: 10.1038/s41598-021-90765-8.

Uremic Toxins, Oxidative Stress, Atherosclerosis in Chronic Kidney Disease, and Kidney Transplantation.

Wojtaszek E, Oldakowska-Jedynak U, Kwiatkowska M, Glogowski T, Malyszko J Oxid Med Cell Longev. 2021; 2021:6651367.

PMID: 33628373 PMC: 7895596. DOI: 10.1155/2021/6651367.

Exploring the potential effect of paricalcitol on markers of inflammation in de novo renal transplant recipients.

Pihlstrom H, Ueland T, Michelsen A, Aukrust P, Gatti F, Hammarstrom C PLoS One. 2020; 15(12):e0243759.

PMID: 33326471 PMC: 7743930. DOI: 10.1371/journal.pone.0243759.

The effect of mannitol on oxidation-reduction potential in patients undergoing deceased donor renal transplantation-A randomized controlled trial.

Reiterer C, Hu K, Sljivic S, von Sonnenburg M, Fleischmann E, Kabon B Acta Anaesthesiol Scand. 2020; 65(2):162-168.

PMID: 32966587 PMC: 7821012. DOI: 10.1111/aas.13713.

References

Heidt S, Roelen D, Eijsink C, Eikmans M, van Kooten C, Claas F . Calcineurin inhibitors affect B cell antibody responses indirectly by interfering with T cell help. Clin Exp Immunol. 2009; 159(2):199-207. PMC: 2810388. DOI: 10.1111/j.1365-2249.2009.04051.x. View

Foley R, Parfrey P, Sarnak M . Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol. 2001; 9(12 Suppl):S16-23. View

Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C . Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 1999; 55(2):648-58. DOI: 10.1046/j.1523-1755.1999.00273.x. View

Port F, Wolfe R, Mauger E, Berling D, Jiang K . Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients. JAMA. 1993; 270(11):1339-43. View

Cofan F, Zambon D, Rodriguez C, Laguna J, Vazquez M, Casals E . Oxidation of low-density lipoproteins in renal transplant recipients. Transplant Proc. 1999; 31(6):2333-4. DOI: 10.1016/s0041-1345(99)00365-6. View

Kato S, Chmielewski M, Honda H, Pecoits-Filho R, Matsuo S, Yuzawa Y . Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol. 2008; 3(5):1526-33. PMC: 4571158. DOI: 10.2215/CJN.00950208. View

Taylor D, Nowell P . Cyclosporin A directly inhibits human B-cell proliferation by more than a single mechanism. J Leukoc Biol. 1985; 38(2):231-9. DOI: 10.1002/jlb.38.2.231. View

Simmons E, Langone A, Sezer M, Vella J, Recupero P, Morrow J . Effect of renal transplantation on biomarkers of inflammation and oxidative stress in end-stage renal disease patients. Transplantation. 2005; 79(8):914-9. DOI: 10.1097/01.tp.0000157773.96534.29. View

Weng P, Hung K, Huang H, Chen J, Sung P, Huang K . Cancer-specific mortality in chronic kidney disease: longitudinal follow-up of a large cohort. Clin J Am Soc Nephrol. 2011; 6(5):1121-8. PMC: 3087779. DOI: 10.2215/CJN.09011010. View

10.

Cueto-Manzano A, Morales-Buenrostro L, Gonzalez-Espinoza L, Gonzalez-Tableros N, Martin-Del-Campo F, Correa-Rotter R . Markers of inflammation before and after renal transplantation. Transplantation. 2005; 80(1):47-51. DOI: 10.1097/01.tp.0000164348.16689.03. View

11.

Simpson R, Hammacher A, Smith D, Matthews J, Ward L . Interleukin-6: structure-function relationships. Protein Sci. 1997; 6(5):929-55. PMC: 2143693. DOI: 10.1002/pro.5560060501. View

12.

Sarnak M, Jaber B . Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int. 2000; 58(4):1758-64. DOI: 10.1111/j.1523-1755.2000.00337.x. View

13.

Evans R, Manninen D, Garrison Jr L, HART L, Blagg C, Gutman R . The quality of life of patients with end-stage renal disease. N Engl J Med. 1985; 312(9):553-9. DOI: 10.1056/NEJM198502283120905. View

14.

Bayes B, Pastor M, Bonal J, Foraster A, Romero R . Oxidative stress, inflammation and cardiovascular mortality in haemodialysis--role of seniority and intravenous ferrotherapy: analysis at 4 years of follow-up. Nephrol Dial Transplant. 2005; 21(4):984-90. DOI: 10.1093/ndt/gfi294. View

15.

Wang Y, Li H, Diao Y, Li H, Zhang Y, Yin C . Relationship between oxidized LDL antibodies and different stages of esophageal carcinoma. Arch Med Res. 2008; 39(8):760-7. DOI: 10.1016/j.arcmed.2008.08.002. View

16.

Canaud B, CRISTOL J, Morena M, Leray-Moragues H, Bosc J, Vaussenat F . Imbalance of oxidants and antioxidants in haemodialysis patients. Blood Purif. 1999; 17(2-3):99-106. DOI: 10.1159/000014381. View

17.

Ghanem H, van den Dorpel M, Weimar W, Man in t Veld A, Jansen H . Increased low density lipoprotein oxidation in stable kidney transplant recipients. Kidney Int. 1996; 49(2):488-93. DOI: 10.1038/ki.1996.69. View

18.

Saito I, Folsom A, Brancati F, Duncan B, Chambless L, McGovern P . Nontraditional risk factors for coronary heart disease incidence among persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Ann Intern Med. 2000; 133(2):81-91. DOI: 10.7326/0003-4819-133-2-200007180-00007. View

19.

Dossus L, Becker S, Rinaldi S, Lukanova A, Tjonneland A, Olsen A . Tumor necrosis factor (TNF)-α, soluble TNF receptors and endometrial cancer risk: the EPIC study. Int J Cancer. 2010; 129(8):2032-7. DOI: 10.1002/ijc.25840. View

20.

Holvoet P, Van Cleemput J, Collen D, Vanhaecke J . Oxidized low density lipoprotein is a prognostic marker of transplant-associated coronary artery disease. Arterioscler Thromb Vasc Biol. 2000; 20(3):698-702. DOI: 10.1161/01.atv.20.3.698. View